Found: 17
Select item for more details and to access through your institution.
Peptide vaccine-treated, long-term surviving cancer patients harbor self-renewing tumor-specific CD8<sup>+</sup> T cells.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30861-z
- By:
- Publication type:
- Article
Programmed cell death-1 is involved with peripheral blood immune cell profiles in patients with hepatitis C virus antiviral therapy.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0299424
- By:
- Publication type:
- Article
Post-allogeneic Hematopoietic Stem Cell Transplantation Portal Hypertension Not Associated with Liver Cirrhosis, Veno-occlusive Disease, or Graft-versus-host Disease.
- Published in:
- Internal Medicine, 2024, v. 63, n. 11, p. 1563, doi. 10.2169/internalmedicine.2489-23
- By:
- Publication type:
- Article
Gastroduodenitis Associated with Active Ulcerative Colitis Treated with Infliximab: Different Clinical Course in the Colon and Gastroduodenal Lesions.
- Published in:
- Internal Medicine, 2024, v. 54, n. 7, p. 929, doi. 10.2169/internalmedicine.2047-23
- By:
- Publication type:
- Article
A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days.
- Published in:
- Nature Medicine, 2013, v. 19, n. 11, p. 1542, doi. 10.1038/nm.3358
- By:
- Publication type:
- Article
Novel Utility of Leucine-Rich Alpha-2-Glycoprotein as a Biomarker in Ulcerative Colitis: A Predictor of Endoscopic Remission Independent of Symptoms.
- Published in:
- Inflammatory Intestinal Diseases, 2023, v. 8, n. 4, p. 133, doi. 10.1159/000534001
- By:
- Publication type:
- Article
Successful second‐line treatment with cabozantinib for hepatocellular carcinoma harboring cytoplasmic mesenchymal–epithelial transition factor amplification.
- Published in:
- Hepatology Research, 2024, v. 54, n. 3, p. 315, doi. 10.1111/hepr.13975
- By:
- Publication type:
- Article
Post-progression survival and progression-free survival in patients with advanced hepatocellular carcinoma treated by sorafenib.
- Published in:
- Hepatology Research, 2016, v. 46, n. 7, p. 650, doi. 10.1111/hepr.12601
- By:
- Publication type:
- Article
Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy.
- Published in:
- Hepatology Research, 2015, v. 45, n. 9, p. 949, doi. 10.1111/hepr.12436
- By:
- Publication type:
- Article
Feasibility and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma after sorafenib.
- Published in:
- Hepatology Research, 2014, v. 44, n. 12, p. 1179, doi. 10.1111/hepr.12266
- By:
- Publication type:
- Article
Myeloid-derived suppressor cells correlate with patient outcomes in hepatic arterial infusion chemotherapy for hepatocellular carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 6, p. 715, doi. 10.1007/s00262-016-1837-2
- By:
- Publication type:
- Article
In vivo immunological antitumor effect of OK-432-stimulated dendritic cell transfer after radiofrequency ablation.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 4, p. 347, doi. 10.1007/s00262-013-1514-7
- By:
- Publication type:
- Article
BMP9‐ID1 signaling promotes EpCAM‐positive cancer stem cell properties in hepatocellular carcinoma.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 8, p. 2203, doi. 10.1002/1878-0261.12963
- By:
- Publication type:
- Article
Modeling of Contagious Credit Events and Risk Analysis of Credit Portfolios.
- Published in:
- Asia-Pacific Financial Markets, 2012, v. 19, n. 1, p. 43, doi. 10.1007/s10690-011-9141-9
- By:
- Publication type:
- Article
Analyses of Mortgage-Backed Securities Based on Unobservable Prepayment Cost Processes.
- Published in:
- Asia-Pacific Financial Markets, 2004, v. 11, n. 3, p. 233, doi. 10.1007/s10690-005-9002-5
- By:
- Publication type:
- Article
ON SURRENDER AND DEFAULT RISKS.
- Published in:
- Mathematical Finance, 2013, v. 23, n. 1, p. 143, doi. 10.1111/j.1467-9965.2011.00487.x
- By:
- Publication type:
- Article
Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0170291
- By:
- Publication type:
- Article